To compare the effect of remifentanil and morphine after coronary artery surgery in a patient-controlled analgesia (PCA) protocol.
I
NTRAVENOUS OPIOIDS ARE the analgesics used most frequently to provide postoperative pain relief after coronary artery bypass graft (CABG) surgery. However, 2 important adverse effects (drowsiness and respiratory depression) caused by opioids may delay patient recovery and rehabilitation. 1 To avoid such situations, better integration of opioid and nonopioid analgesics and use of short-acting opioids may decrease opioid-related adverse effects and result in better patient satisfaction. The selective -opioid agonist, remifentanil, has a fast onset and an ultrashort duration of action, causes minimal adverse effects, and shows organ-independent metabolism. 2 However, the safety of remifentanil in awake and spontaneously breathing patients during the postoperative period has not been established. It can cause sudden respiratory depression in spontaneously breathing patients. Cessation of remifentanil leads to hyperalgesia in a few minutes due to withdrawal of the analgesic effect. For this reason, the use of remifentanil as a patient-controlled postoperative analgesic medication has been limited. [3] [4] [5] There are very few studies about manually titrated continuous infusion or intravenous patient-controlled analgesia (IV-PCA) of remifentanil. [6] [7] [8] [9] [10] Studies in which patient-controlled analgesia of remifentanil was used postoperatively have been limited to the duration of the remifentanil infusion; no additional analgesic medications were administered concomitantly with opioids. 9, 10 It should be remembered, however, that the quick offset of action of remifentanil may result in inadequate pain relief during the postoperative period.
The primary aims of this study were to investigate the effectiveness of IV-PCA of remifentanil in an overall analgesia protocol and to determine patient satisfaction with that treatment. The second endpoint was to compare the results of this study with those of a standard treatment in which morphine was administered as IV-PCA.
METHODS
After approval of the study protocol had been granted by the institutional review board and written informed consent had been obtained from each subject, 60 patients scheduled to undergo elective primary CABG surgery who had a ventricular ejection fraction greater than 35% and an American Society of Anesthesiologists grade II to III were randomly divided into 2 groups prospectively in a double-blind manner. Sample size was calculated with an expected parameter estimate based on the study by Gurbet et al. 9 Assuming a mean of 0.7 on the numeric rating scale (NRS) in group R and a mean of 0.5 in group M with a 0.3 standard deviation at 24 hours after surgery, the minimum sample size in each study group thus required within a 90% confidence and 80% power was approximately 28. Post hoc power was 52.9% for a 90% confidence.
Randomization was performed with the closed-envelope technique. All patients were blinded to their treatment group. The exclusion criteria were as follows: chronic renal insufficiency (a serum creatinine level of Ͼ1.5 mg/dL), results from preoperative liver function tests that were not within the reference range, chronic obstructive pulmonary disease based on long-term use of bronchodilators or steroids for lung disease, stroke, a pulmonary artery pressure of more than 25 mmHg (as indicated by a preoperative transthoracic echocardiogram), an American Society of Anesthesiologists/New York Heart Association classification of more than 3, or the need for emergency surgery. Patients also were excluded if they required reoperation for the treatment of hemorrhage or developed cardiac failure (postoperative high-dose inotropic support or the intraoperative or postoperative insertion of an intra-aortic balloon pump).
The night before surgery, all patients were familiarized with the NRS and the PCA pump (Abbott Pain Manager; Abbott Laboratories, North Chicago, IL). In all patients, anesthetic management and coronary artery bypass surgery were done uniformly, according to standard procedures. Anesthesia was induced in all patients with thiopental (3-5 mg/kg), fentanyl (8-10 g/kg), and vecuronium (0.08 mg/kg) and was maintained with a fentanyl infusion (8 g/kg/h), 0.5% to 0.7% isoflurane in an oxygen-air mixture, and intravenous injections of vecuronium (0.02 mg/kg every 30 minutes). The surgical approach was through a midline sternotomy, with the sternal side (where the internal mammary artery will be obtained) elevated with a special rectractor. The internal mammary artery pedicle was mobilized from the chest wall by cautery. Saphenous vein harvesting from the calf was accomplished by using a standard open incision. Intravenous heparin (300 IU/kg) was administered as needed to keep the activated coagulation time longer than 480 seconds. Cardiopulmonary bypass was instituted in a standard manner by cannulating the right atrium and the ascending aorta. The patient was cooled to the level of mild hypothermia (body temperature, 32°C-34°C). During cardiopulmonary bypass, hematocrit was kept between 24% and 28%, pump flow rates were kept between 2.0 and 2.5 L/min/m 2 , and mean arterial pressure was kept at 70 to 80 mmHg using sodium nitroprusside or norepinephrine as required. In all cases, myocardial preservation was achieved with antegrade and retrograde nondiluted cardioplegia (minicardioplegia). All distal and proximal anastomoses were performed during a single cross-clamping period. The sternotomy was closed with 6 or 7 sternal wires, and the skin incision was closed with intracutaneous stitches. Mediastinal and thoracic drains were passed through the rectus abdominis muscles just below the xiphoid area. At the end of surgery, the fentanyl infusion was stopped, and all patients received paracetamol (acetaminophen), 650 mg, in the form of a rectal suppository.
After the operation, patients were transferred to the intensive care unit (ICU) where they were weaned from mechanical ventilation after the following criteria had been achieved: hemodynamic stability, a body temperature greater than 36°C, chest tube output of less than 100 mL/h, and a ratio of arterial partial pressure of oxygen (PaO 2 ) to F I O 2 of more than 300. After the patients were awake and could respond to commands, they were shifted to a pressure-support ventilation mode. Respiratory mechanics were evaluated, and, if those results were appropriate (ie, a respiratory rate of 10 to 28 breaths/min, a tidal volume of Ͼ5 mL/kg, a vital capacity of Ͼ10 mL/kg, and a negative inspiratory force of Յ20 cmH 2 O), then the patient underwent extubation.
IV-PCA opioid infusions were initiated on arrival in the ICU. The drugs were prepared by an anesthesiologist who did not participate in the study. To ensure that the study was executed according to the double-blind protocol, background infusions were administered with an infusion pump (JMS Co, Ltd, Hiroshima, Japan). Only bolus doses were administered with the PCA pump. Although the rate of infusion of the 2 agents was similar, the concentration of these drugs differed. It was determined by the weight of each patient as follows: in group R, the remifentanil infusion was programmed at 0.05 g/kg/min (1 mL/h), a bolus of 0.25 g/kg (1 mL), and a lockout time of 5 minutes. In group M, the morphine infusion was programmed as 0.3 mg/h (1 mL/h), a bolus of 1 mg (1 mL), and a lockout time of 5 minutes. Both groups received (in addition to PCA) paracetamol in a dosage of 1,000 mg 4 times per day through a nasogastric tube and then 500 mg 4 times per day orally after extubation. Patients who were agitated before extubation received intravenous midazolam, 2 mg, and those who experienced shivering were given intravenous meperidine, 20 mg. Those who cooperated before extubation and had an NRS of 3 or more received a self-administered bolus dose of opioids via the PCA device. IV-PCA opioid infusions were discontinued after 24 hours. Tramadol (a synthetic atypical opioid with about one tenth the potency of morphine) was administered orally (50 mg 4 times per day) for pain relief 24 hours after surgery and 10 minutes before the IV-PCA administration was terminated. During postprocedure hours 24 to 72, if a patient's NRS was 3 or more despite pain-relief therapy, then that individual received orally administered morphine sulfate, 10 mg.
During follow-up, all patients were monitored by the same investigator (S.B.). Pain was assessed, with each patient at rest, coughing, or moving by using an 11-point rating scale in which zero represented "no pain" and 10 indicated the "worst pain imaginable." Pain scores were documented at 2, 3, 4, 5, 6, 12, 24, 36, 48, 60, and 72 hours after surgery. In addition, the amounts of the PCA bolus, infusions, and the requirement for morphine were determined 24 hours after surgery. Sedation levels were evaluated with the Ramsay sedation score. 11 The hourly measurement of mean arterial blood pressure and heart rate, electrocardiography with continuous ST-segment analysis, respiratory rate, and oxygen saturation were recorded. Arterial blood gas analysis was recorded 0, 2, 6, 12, and 24 hours after surgery. Respiratory depression was defined as apnea or a respiratory rate of fewer than 8 breaths/min. A daily anteroposterior chest radiograph obtained until the fourth postoperative day was compared with a previous chest radiograph to identify atelectasis and other pulmonary complications. All chest radiographs were evaluated by a radiologist blinded to the treatment administered.
The time of the patients' ability to first cooperate (Ramsay sedation score, 2), the time of extubation, and the duration of the stay in the ICU and in the hospital were obtained from medical records. Adverse events including nausea, vomiting, muscle rigidity, apnea, respiratory depression, and bradycardia also were recorded. Nausea and vomiting were assessed within 15 minutes after first cooperation and extubation, at the time of discontinuation of the PCA analgesic infusion in the first day, and 3 times in the second and third days.
Statistical analyses were done with SPSS software (Statistical Product and Services Solutions, version 9.05; SPSS Inc, Chicago, IL). Postoperative NRS values were used as the primary parameter when the sample size was determined.
All variables are given as means Ϯ standard deviation, as percentages (n), or as medians (range). After assessing the outcome distribution, pain and sedation scores were not normally distributed. These scores are reported as medians with a range, and a nonparametric test was used to analyze statistical significance. To compare quantitative data between the study groups, the t test was used for parametric values, and the Wilcoxon signed-rank test was used for nonparametric values. Qualitative data between the groups were compared with the chi-square test. A value of p Ͻ 0.05 was accepted as statistically significant.
RESULTS
Sixty patients (30 in group R and 30 in group M) were accepted as study subjects. One patient who experienced severe agitation in postoperative group R and 1 patient who required reoperation for bleeding in group M were excluded from the study. Thus, 29 patients in each treatment group completed the study. Preoperative patient characteristics, risk assessment, and intraoperative data were similar in both groups ( Table 1 ). The duration of mechanical ventilation was similar in both groups (group R, 8.5 Ϯ 3.6 hours; group M, 9.0 Ϯ 3.4 hours). Eight patients (4 in group R and 4 in group M) underwent mechanical ventilation for more than 24 hours because of continuing drainage from a chest tube. In 1 patient in group R, a brief period of shallow respiration lasting 30 seconds was observed after extubation, but that patient's respiration improved without additional intervention. Patients' length of stay in the ICU (group R, 46.83 Ϯ 4.5 hours; group M, 45.44 Ϯ 5.6 hours) and length of stay in the hospital after the operation (group R, 5.2 Ϯ 1 days; group M, 5.1 Ϯ 1 days) were similar.
Two patients pressed the PCA button 4 times before extubation in group R, and 4 patients pressed the PCA button 10 times before extubation in group M (p Ͼ 0.05). Intravenous midazolam was administered to 5 patients in group R and to 3 patients in group M because agitation developed before extubation (p Ͼ 0.05). The total dose (5.0 Ϯ 3 mg v 2.2 Ϯ 1 mg) of administered midazolam was similar in group R and in group M, respectively (p Ͼ 0.05). Twenty milligrams of intravenous meperidine were administered to 2 patients in group R to treat shivering.
No statistically significant difference was observed between the 2 groups with regard to the NRS at rest during the first 24 hours when PCA was used. During coughing, the NRS values were statistically significantly lower in the group R than they were in group M at 12 and 24 hours after surgery (median 1 v 3 at 12 hours and 2 v 3.5 at 24 hours) (p Ͻ 0.05). On movement, NRS values were statistically significantly lower in group R than they were in group M at 12 hours after surgery (median 1 v 2.5) (p Ͻ 0.05) ( Table 2) .
After 24 hours of PCA use, no statistically significant difference was observed between the 2 groups when bolus and demand ratios were calculated ( Table 3 ). The 2 groups were similar with regard to the need for additional oral analgesic medication between the 24th and 72nd hours after surgery. Tramadol was discontinued in 5 patients in both groups after the 48th postoperative hour because of nausea and/or drowsiness that restricted mobility. Those 10 patients did not require further analgesic medication other than paracetamol. The Ramsay sedation score was statistically significantly lower at the 6th postoperative hour in group R than in group M (median 2 v 3) (p Ͻ 0.05). After the 24th hour, that score (value, 2) was similar in both groups. The incidence of nausea was markedly higher in group M than it was in group R after the first 24 hours (p Ͻ 0.05). The incidence of vomiting was similar in both groups ( Table 4) .
The number of complications in the postoperative periods did not differ between the 2 groups during the 72-hour study period (Table 4) . Postoperative 2nd-day and 3rd-day chest radiographs revealed atelectasis in 4 patients (14%) in each group, but no intervention other than routine chest physiotherapy was needed in these individuals. In 1 patient in group M, delirium was observed at 30 hours after surgery. No statistically 
